Literature DB >> 18222620

Agrin and neuregulin, expanding roles and implications for therapeutics.

Stacey Williams1, Colleen Ryan, Christian Jacobson.   

Abstract

Agrin and neuregulin are broadly expressed molecules that have significant developmental roles. Here we review the diverse temporal and spatial expression patterns and functions of these molecules and the impact that dysregulation may have on a number of disease states. Many know agrin as a modulator of synaptogenesis and the neuregulins for their prominent role in breast cancer; this review elaborates on many of the other proposed functions for these molecules both in the nervous system and elsewhere. In several instances we discuss the possible use of agrin, neuregulin and related molecules as therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18222620     DOI: 10.1016/j.biotechadv.2007.11.003

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  4 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

2.  Agrin-signaling is necessary for the integration of newly generated neurons in the adult olfactory bulb.

Authors:  Katja Burk; Angelique Desoeuvre; Camille Boutin; Martin A Smith; Stephan Kröger; Andreas Bosio; Marie-Catherine Tiveron; Harold Cremer
Journal:  J Neurosci       Date:  2012-03-14       Impact factor: 6.167

Review 3.  Multifunctionality of extracellular and cell surface heparan sulfate proteoglycans.

Authors:  Catherine Kirn-Safran; Mary C Farach-Carson; Daniel D Carson
Journal:  Cell Mol Life Sci       Date:  2009-07-24       Impact factor: 9.261

4.  Integrated analysis of fine-needle-aspiration cystic fluid proteome, cancer cell secretome, and public transcriptome datasets for papillary thyroid cancer biomarker discovery.

Authors:  Chia-Chun Wu; Jen-Der Lin; Jeng-Ting Chen; Chih-Min Chang; Hsiao-Fen Weng; Chuen Hsueh; Hui-Ping Chien; Jau-Song Yu
Journal:  Oncotarget       Date:  2018-01-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.